Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Change in Account Payables (2023 - 2025)

Camp4 Therapeutics' Change in Account Payables history spans 3 years, with the latest figure at -$467000.0 for Q4 2025.

  • For Q4 2025, Change in Account Payables rose 45.44% year-over-year to -$467000.0; the TTM value through Dec 2025 reached -$1.0 million, down 711.9%, while the annual FY2025 figure was -$1.0 million, 711.9% down from the prior year.
  • Change in Account Payables for Q4 2025 was -$467000.0 at Camp4 Therapeutics, up from -$546000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $1.1 million in Q3 2024 and bottomed at -$1.0 million in Q2 2024.
  • The 3-year median for Change in Account Payables is -$190000.0 (2025), against an average of -$112222.2.
  • The largest annual shift saw Change in Account Payables crashed 470.67% in 2024 before it soared 81.8% in 2025.
  • A 3-year view of Change in Account Payables shows it stood at -$150000.0 in 2023, then plummeted by 470.67% to -$856000.0 in 2024, then skyrocketed by 45.44% to -$467000.0 in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Change in Account Payables are -$467000.0 (Q4 2025), -$546000.0 (Q3 2025), and -$190000.0 (Q2 2025).